Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans- tetrahydrocannabinol (delta-9-THC)] in Schedule II. Final rule

scientific article published in November 2017

Schedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans- tetrahydrocannabinol (delta-9-THC)] in Schedule II. Final rule is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID29232070

P2093author name stringDrug Enforcement Administration, Department of Justice.
P433issue224
P304page(s)55504-55506
P577publication date2017-11-01
P1433published inFederal RegisterQ5440362
P1476titleSchedules of Controlled Substances: Placement of FDA-Approved Products of Oral Solutions Containing Dronabinol [(-)-delta-9-trans- tetrahydrocannabinol (delta-9-THC)] in Schedule II. Final rule
P478volume82